TNYA: חובות מצטברים של החברה Tenaya Therapeutics Inc

Current price action for Tenaya Therapeutics (TNYA) reflects a debt position currently standing at 0.01. Tenaya Therapeutics is developing innovative gene-correction methods for cardiac pathologies, leveraging a unique technological stack and the interest of pharmaceutical behemoths in its research. The business's environmental profile is limited solely to the regulated disposal of biological waste, with no global climate plan in place.

This metric aggregates all of the issuer's credit obligations, providing a real-time reflection of debt capital dynamics. It measures financial leverage, determining the extent to which business development depends on external financing. For Tenaya Therapeutics (TNYA), such funds are critical for organizing the costly cold chain required for transporting biomaterials. An increase in borrowings may indicate the scaling of clinical trials. By analyzing changes in the company's liabilities, an investor assesses the balance between expansion and debt load.